3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
11
Neoplasms
8
Head and Neck Neoplasms
8
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Sarcoma
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Psychological Well-Being
2
Motor Activity
2
Melanoma
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Communication
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
pembrolizumab
22
Nivolumab
14
enfortumab vedotin
13
Gemcitabine
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
Cisplatin
8
Carboplatin
8
sacituzumab govitecan
6
Docetaxel
6
avelumab
5
atezolizumab
5
Ipilimumab
5
durvalumab
4
Paclitaxel
4
cabozantinib
3
Taxes
3
Mitomycin
3
CTLA-4 Antigen
3
tislelizumab
2
relatlimab
2
erdafitinib
2
disitamab vedotin
2
Radiosurgery
2
Platinum
2
Oxaliplatin
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
ALT-803
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Surveys and Questionnaires
×
90 days
×
Clear all
No trials found.